The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Interaction of the Cyclic Antimicrobial Cationic Peptide Bactenecin with the Outer and Cytoplasmic Membrane
Open accessAbstract
Bactenecin, a 12-amino acid cationic antimicrobial peptide from bovine neutrophils, has two cysteine residues, which form one disulfide bond, making it a cyclic molecule. To study the importance of the disulfide bond, a linear derivative Bac2S was made and the reduced form (linear bactenecin) was also included in this study. Circular dichroism spectroscopy showed that bactenecin existed as a type I beta-turn structure regardless of its environment, while the reduced form and linear bactenecin adopted different conformations according to the lipophilicity of the environment. Bactenecin was more active against the Gram-negative wild type bacteria Escherichia coli, Pseudomonas aeruginosa, and Salmonella typhimurium than its linear derivative and reduced form, while all three peptides were equally active against the outer membrane barrier-defective mutants of the first two bacteria. Only the two linear peptides showed activity against the Gram-positive bacteria Staphylococcus epidermidis and Enterococcus facaelis. Bactenecin interacted well with the outer membrane and its higher affinity for E. coli UB1005 lipopolysaccharide and improved ability to permeabilize the outer membrane seemed to account for its better antimicrobial activity against Gram-negative bacteria. The interaction of bactenecin with the cytoplasmic membrane was determined by its ability to dissipate the membrane potential by using the fluorescence probe 3, 3-dipropylthiacarbocyanine and an outer membrane barrier-defective mutant E. coli DC2. It was shown that the linear derivative and reduced form were able to dissipate the membrane potential at much lower concentrations than bactenecin despite the similar minimal inhibitory concentrations of all three against this barrier-defective mutant.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Antibiotics in Laboratory Medicine.
(1980) · Annals of Internal Medicine · doi:10.7326/0003-4819-93-4-653_4 · Cited by 2,779
Circular Dichroism and the Conformational Analysis of Biomolecules
(1996) · Springer eBooks · doi:10.1007/978-1-4757-2508-7 · Cited by 1,930
The toxic shock syndrome exotoxin structural gene is not detectably transmitted by a prophage
Kreiswirth, B. N., Löfdahl, S., Betley, M. J., O'Reilly, M., Schlievert, P. M., Bergdoll, M. S., & Novick, R. P. (1983) · Nature · doi:10.1038/305709a0 · Cited by 1,326
Hancock, R. E. (1997) · The Lancet · doi:10.1016/s0140-6736(97)80051-7 · Cited by 1,096
Self-citationSims, P. J., Waggoner, A. S., Wang, C.-H., & Hoffman, J. F. (1974) · Biochemistry · doi:10.1021/bi00713a022 · Cited by 951
Boman, H. G., & Hultmark, D. (1987) · Annual Review of Microbiology · doi:10.1146/annurev.mi.41.100187.000535 · Cited by 740
Interaction of human defensins with Escherichia coli. Mechanism of bactericidal activity.
Lehrer, R. I., Barton, A., Daher, K. A., Harwig, S. S., Ganz, T., & Selsted, M. E. (1989) · Journal of Clinical Investigation · doi:10.1172/jci114198 · Cited by 715
Antibiotics in Laboratory Medicine
White, W. (1992) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1992.03480090121040 · Cited by 669
A Salmonella Locus that Controls Resistance to Microbicidal Proteins from Phagocytic Cells
Fields, P. I., Groisman, E. A., & Heffron, F. (1989) · Science · doi:10.1126/science.2646710 · Cited by 540
Christensen, B., Fink, J., Merrifield, R. B., & Mauzerall, D. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.14.5072 · Cited by 514
Cited by
Hancock, R. E. W., & Chapple, D. S. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.6.1317 · Cited by 1,190
Self-citationCorrelation of Daptomycin Bactericidal Activity and Membrane Depolarization in Staphylococcus aureus
Silverman, J. A., Perlmutter, N. G., & Shapiro, H. M. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.8.2538-2544.2003 · Cited by 656
Ageitos, J. M., Sánchez-Pérez, A., Calo-Mata, P., & Villa, T. G. (2017) · Biochemical Pharmacology · doi:10.1016/j.bcp.2016.09.018 · Cited by 614
Hartmann, M., Berditsch, M., Hawecker, J., Ardakani, M. F., Gerthsen, D., & Ulrich, A. S. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00124-10 · Cited by 543
Antibacterial Action of Structurally Diverse Cationic Peptides on Gram-Positive Bacteria
Friedrich, C. L., Moyles, D., Beveridge, T. J., & Hancock, R. E. W. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.8.2086-2092.2000 · Cited by 464
Self-citationSmall Bioactive Peptides for Biomaterials Design and Therapeutics
Hamley, I. W. (2017) · Chemical Reviews · doi:10.1021/acs.chemrev.7b00522 · Cited by 461
Polymyxin: Alternative Mechanisms of Action and Resistance
Trimble, M. J., Mlynárčik, P., Kolář, M., & Hancock, R. E. W. (2016) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a025288 · Cited by 454
Self-citationOuhara, K., Komatsuzawa, H., Yamada, S., Shiba, H., Fujiwara, T., Ohara, M., Sayama, K., Hashimoto, K., Kurihara, H., & Sugai, M. (2005) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dki103 · Cited by 428
Yin, L. M., Edwards, M. A., Li, J., Yip, C. M., & Deber, C. M. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.303602 · Cited by 423
High-throughput generation of small antibacterial peptides with improved activity
Hilpert, K., Volkmer-Engert, R., Walter, T., & Hancock, R. E. W. (2005) · Nature Biotechnology · doi:10.1038/nbt1113 · Cited by 375
Self-citationColistin Methanesulfonate Is an Inactive Prodrug of Colistin against Pseudomonas aeruginosa
Bergen, P. J., Li, J., Rayner, C. R., & Nation, R. L. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00035-06 · Cited by 366
Antimicrobial Peptides: A Potent Alternative to Antibiotics
Rima, M., Rima, M., Fajloun, Z., Sabatier, J.-M., Bechinger, B., & Naas, T. (2021) · Antibiotics · doi:10.3390/antibiotics10091095 · Cited by 350
Zhang, L., Dhillon, P., Yan, H., Farmer, S., & Hancock, R. E. W. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.12.3317-3321.2000 · Cited by 349
Self-citationStructural features and biological activities of the cathelicidin-derived antimicrobial peptides
Gennaro, R., & Zanetti, M. (2000) · Biopolymers · doi:10.1002/1097-0282(2000)55:1<31::aid-bip40>3.0.co;2-9 · Cited by 291
Scott, M. G., Vreugdenhil, A. C. E., Buurman, W. A., Hancock, R. E. W., & Gold, M. R. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.2.549 · Cited by 270
Self-citationCathelicidins: microbicidal activity, mechanisms of action, and roles in innate immunity
Ramanathan, B., Davis, E. G., Ross, C. R., & Blecha, F. (2002) · Microbes and Infection · doi:10.1016/s1286-4579(02)01549-6 · Cited by 268
Synergistic Interactions between Mammalian Antimicrobial Defense Peptides
Yan, H., & Hancock, R. E. W. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.5.1558-1560.2001 · Cited by 259
Self-citationPapo, N., & Shai, Y. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m412865200 · Cited by 253
Li, M., Cheung, G. Y. C., Hu, J., Wang, D., Joo, H., DeLeo, F. R., & Otto, M. (2010) · The Journal of Infectious Diseases · doi:10.1086/657419 · Cited by 175
Antimicrobial peptides: promising compounds against pathogenic microorganisms
Cruz, J., Ortiz, C., Guzmán, F., Fernández-Lafuente, R., & Torres, R. (2014) · Current Medicinal Chemistry · doi:10.2174/0929867321666140217110155 · Cited by 166
Metadata
- Authors
- Wu, M., & Hancock, R. E. W.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 1999-01
- Volume
- 274
- Issue
- 1
- Pages
- 29-35
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2111667046
- Cited by
- 356
- References
- 27
- FWCI
- 9.76
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.